An end-to-end population genomics platform

From recruitment support to Exome+® sequencing to return of results, we enable you to bring the power of genomics to your communities.

DNA Helix in shades of blue

A panel-grade clinical exome

The Exome+ assay delivers the benefits of a targeted panel, the breadth of a microarray, and the completeness of an exome all from one assay

Beaker in shades of blue

Genomics research platform

The Helix platform, with its dedicated clinical and research teams, supports you in delivering actionable genetic insights and conducting large-scale genetic analyses

Lightbulb in shades of blue

Sequence once, query often

Helix sequences and securely stores Exome+ data on behalf of each participant enabling flexible and on-demand access to genomic data, with the proper consent

COVID-19 testing

We've launched a sensitive, scalable, end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country.

 

Our test system includes a non-invasive collection kit, processing of samples in our CLIA-certified, CAP-accredited high-complexity laboratory in San Diego, next-day turnaround time, and return of results to the ordering healthcare professional, the tested individual, and public health agencies, as necessary. We have also partnered with Illumina to launch a viral surveillance program.

Learn more

Viral surveillance sequencing program

Helix and Illumina, with support from the CDC, are collaborating to augment national surveillance infrastructure in the US to track the emergence and prevalence of novel variants of SARS-CoV-2. Sequences are deposited regularly to GISAID and Genbank by the CDC. All B.1.1.7 variants are also reported to relevant public health departments for contact tracing efforts.

See dashboard

.

Privacy is one of our top priorities.

We won’t share data without a participant’s permission. We pledge to uphold the highest standards of bioethics and maintain rigorous policies and procedures to keep data safe and secure.

Learn how we protect data

Partner with us

Helix provides the infrastructure and services to help you carry out population-scale genomic screening and research initiatives, including one of the world's largest CLIA / CAP next-generation sequencing labs. Together, we can drive earlier identification of at-risk individuals and accelerate innovative research efforts.

Learn more

*Panel-grade: defined as a ~100% call rate across every base within clinically relevant panels (offering equivalent or superior quality to clinical panels in the market).